Abstract:BACKGROUND:Menin is a ubiquitously expressed protein encoded by the multiple endocrine neoplasia type 1 (MEN1) gene. Besides its importance in endocrine organs, menin has been shown to interact with the mixed lineage leukemia (MLL) protein, a histone H3 lysine 4 methyltransferase, and plays a critical role in hematopoiesis and leukemogenesis. Previous studies have shown that menin promotes transforming growth factor beta (TGF-β) signaling in endocrine cells. However, little is known regarding the impact of TGF-β pathway on menin in hematopoietic system. Here, with leukemia cell lines generated from conditional MEN1 or TGF-β receptor (TβRII) knockout mouse models, we investigated the possible cross-talk of these two pathways in leukemia cells.METHODS:MEN1 or TβRII conditional knockout mice were bred and the bone marrow cells were transduced with retroviruses expressing oncogeneic MLL-AF9 (a mixed lineage leukemia fusion protein) to generate two leukemia cell lines. Cell proliferation assays were performed to investigate the effect of TGF-β treatment on MLL-AF9 transformed leukemia cells with/without MEN1 or TβRII excision. Menin protein was detected with Western blotting and mRNA levels of cell proliferation-related genes Cyclin A(2) and Cyclin E(2) were examined with real-time RT-PCR for each treated sample. In vivo effect of TGF-β signal on menin expression was also investigated in mouse liver tissue after TβRII excision.RESULTS:TGF-β not only inhibited the proliferation of wild type MLL-AF9 transformed mouse bone marrow cells, but also up-regulated menin expression in these cells. Moreover, TGF-β failed to further inhibit the proliferation of Men1-null cells as compared to Men1-expressing control cells. Furthermore, excision of TβRII, a vital component in TGF-β signaling pathway, down-regulated menin expression in MLL-AF9 transformed mouse bone marrow cells. In vivo data also confirmed that menin expression was decreased in liver samples of conditional TβRII knockout mice after TβRII excision.CONCLUSION:These results provided the first piece of evidence of cross-talk between menin and TGF-β signaling pathways in regulating proliferation of leukemia cells, suggesting that manipulating the cross-talk of the two pathways may lead to a novel therapy for leukemia.

Menin Promotes Hepatocellular Carcinogenesis And Epigenetically Up-Regulates Yap1 Transcription

Menin Enhances C-Myc-mediated Transcription to Promote Cancer Progression

Menin Epigenetically Represses Hedgehog Signaling in Men1 Tumor Syndrome

Menin in Cancer

Progress on Biological Function of MEN 1 Gene

Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1

Menin Represses Malignant Phenotypes Of Melanoma Through Regulating Multiple Pathways

The Tumor Suppressor Protein Menin Inhibits NF-κB-mediated Transactivation Through Recruitment of Sirt1 in Hepatocellular Carcinoma

Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPARγ

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

Hepatic Menin Recruits SIRT1 to Control Liver Steatosis Through Histone Deacetylation.

Menin Expression is Regulated by Transforming Growth Factor Beta Signaling in Leukemia Cells.

Functional Interaction Between Tumor Suppressor Menin And Activator Of S-Phase Kinase

Suppression of Lung Adenocarcinoma Through Menin and Polycomb Gene-Mediated Repression of Growth Factor Pleiotrophin

MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation

Applications of MEN1 gene and encoding protein thereof

Interplay between Menin and K-Ras in Regulating Lung Adenocarcinoma

Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription

MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer

Direct Binding of DNA by Tumor Suppressor Menin.

A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology